games

Approval Within 24 Hours
We are shifting DB. Members may see some problems

Search:

Business News's Articles in Breast-Cancer

  • HistoRx Names John Tonkinson, Ph.D., Vice President, Business Development
    HistoRx, Inc. announced today that John L. Tonkinson, Ph.D. has been appointed to Vice President, Business Development. HistoRx is developing and commercializing a new generation of companion diagnostics, which will initially be focused on breast cancer. Dr. Tonkinson will oversee HistoRx's growing number of alliances with pharmaceutical and biotechnology companies.
  • Power3 Chairman/CEO Steven Rash to Discuss Progress in Early Detection Blood Testing
    Steven Rash, chairman and CEO of Power3 Medical Products, Inc. (PWRM.PK), a leading proteomics company that develops and commercializes early detection diagnostic tests for breast cancer and neurodegenerative diseases, will discuss his company's progress in developing blood-based early detection testing in an online radio interview available worldwide tomorrow (Tuesday).
  • CS-Keys Garners Investment from Triathlon Medical Ventures
    CS-Keys, Inc. (CS-Keys) announced today a significant seed investment in the company by Midwest-based Triathlon Medical Ventures (Triathlon). CS-Keys has developed a new diagnostic tool that can help detect cancer in its earliest stages, with an initial focus on breast cancer.
  • Neoprobe Initiates Lymphoseek Phase 2 Clinical Study
    Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative oncology and cardiovascular surgical and diagnostic products, today announced that it has initiated its Phase 2 multi-center clinical study of Lymphoseek(TM), a lymphatic tissue targeting agent being developed by the Company. Neoprobe was granted authorization by FDA earlier this year to commence patient enrollment in a Phase 2 multi-center clinical study to evaluate the safety and efficacy of Lymphoseek.

| |

севастополь

Powered by Article Dashboard